Atlas Trials

Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer

Clinical trial NCT00877253 · COMPLETED

Trial details

NCT number
NCT00877253
Sponsor
Samyang Biopharmaceuticals Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2008-05-01
Primary completion
2009-06-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.